GLP-1 Telehealth Providers in Texas

Yes. Texas allows telehealth prescribing of GLP-1 medications with wide provider availability.

Yes. Texas has some of the broadest provider availability in the country, with most major platforms operating in the state.

Yes. Texas has many compounding pharmacies and compounded semaglutide and tirzepatide are readily available.

Texas Medicaid (STAR program) covers GLP-1 medications for type 2 diabetes management but does not broadly cover them for standalone weight loss. If you have both type 2 diabetes and obesity, you may qualify. Coverage varies by managed care organization. Contact yours directly to confirm whether weight management indications are covered.

FDA removed semaglutide from the drug shortage list in early 2025, ending 503B compounding. Texas-licensed 503A compounding pharmacies may still fill individual prescriptions under specific conditions, but this pathway has become more limited. Availability varies by pharmacy. Ask your telehealth provider directly whether 503A-compounded semaglutide is an option in your case.

No referral is required to start a telehealth GLP-1 evaluation in Texas. For insurance coverage, prior authorization from your plan is almost always required. Cash-pay telehealth programs can issue a prescription after an online intake without a referral. Most complete this within 24–72 hours.

Texas residents can typically start a telehealth GLP-1 program within 24–72 hours through async platforms that accept written intakes and lab submissions. Video-based consultations are usually available within 2–5 business days. Once prescribed, medication ships to your door. Delivery takes 3–7 days depending on the dispensing pharmacy.